About Altoida
Altoida is a Healthcare company based in Lucerne (Switzerland) founded in 2016 by Richard Fischer and Maximilian Buegler. Provider of a AI-based app which can predict the onset of Alzheimers. Altoida has raised $20.3 million across 5 funding rounds from investors including M-Ventures, Whitecap VP and HonorHealth. Its chief executive, as recorded, is Richard Fischer. Its website altoida.com draws about 32 thousand monthly visits. Altoida offers products and services including NeuroMarker Platform and Digital Cognitive Assessment. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is ALTOIDA INC.
Company details
Altoida was founded in 2016 and is based in Lucerne, Switzerland. An AI-driven mobile application is offered by the company to forecast the early stages of Alzheimers disease. Interactive activities are incorporated to measure neuromotor biomarkers, which are processed for diagnostic insights. Operations are centered in the digital health sector, with a focus on neurodegenerative conditions and preventive assessments.
- Headquarters Lucerne, Switzerland
- Founders Richard Fischer, Maximilian Buegler
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website altoida.com
- Social LinkedIn X Facebook
- Legal Name Altoida Inc
- Total Equity Funding$20.3M (USD)
in 5 rounds
- Latest Funding Round$14M (USD), Series A
Mar 2022
- InvestorsM-Ventures
& 10 more
Products & Services of Altoida
Altoida offers a comprehensive portfolio of products and services, including NeuroMarker Platform and Digital Cognitive Assessment.
Tool for early detection of cognitive decline using sensor-based tasks.
Self-administered test for rapid evaluation of brain health in 10 minutes.
Funding Insights of Altoida
Altoida has successfully raised a total of $20.3M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $14 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $20.3M
- Total Rounds 5
- Last Round Series A — $14M
- First Round $32,828
(Jun 2016)
- Investors Count 11
All 5 funding rounds of Altoida with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2022 | $14M | Series A | – | M Ventures, Whitecap Venture Partners | |
| Jul 2021 | Series A | – | Eisai Innovation | – | |
| May 2020 | Series A | – | Hikma Ventures | – | |
| Apr 2019 | $6.3M | Series A | – | M Ventures | |
| Jun 2016 | $32,828 | Grant | – | – |
11 investors in total: 11 institutional.
Investors in Altoida
Altoida has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include M-Ventures, Whitecap VP and HonorHealth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in multiple sectors | m-ventures.com | Amsterdam, Netherlands | ||
Whitecap VP is engaged in venture capital investments for startups. | whitecapvp.com | Toronto, Canada | ||
Hikma Ventures is focused on digital health investments. | 2015 | hikmaventures.com | London, United Kingdom | |
Early-stage tech startups are invested in by Alpana Ventures. | alpana-ventures.ch | Geneva, Switzerland | ||
Early-stage venture capital is invested in US and Europe. | vipartners.ch | Altendorf, Switzerland | ||
Early-stage US companies are invested in by Fyrfly Venture Partners. | fyrfly.vc | San Francisco, United States | ||
Venture capital is provided to innovative startups by b2venture. | b2venture.vc | St. Gallen, Switzerland | ||
Private equity firm focused on biotech and healthcare sectors | eisaiinnovation.com | Cambridge, United States | ||
| gsvp.com | ||||
University backed startup accelerator | venturekick.ch | Schlieren, Switzerland |
Investor details for Altoida
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Altoida
22 people are tracked at Altoida (16 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Richard Fischer | Co-Founder & CEO | Leadership |
Maximilian Buegler | Co-Founder & CTO | Leadership |
Maximilian Bügler | CTO | Leadership |
Marc Jones | Chief Executive Officer And Board Director | Leadership |
M. Florencia Iulita | Head Medical Strategy and Operations | Leadership |
Emmanuel S. | Sr. Medical Affairs Director | Leadership |
Abel zhao | chief operating officer | Leadership |
Dr. Maximilian Bügler | Chief Technology Officer | Leadership |
Arnd Kaltofen-Ehmann | Board Director | Leadership |
Melinda Decker | Advisor and Fractional Chief Commercial Officer (CCO) | Leadership |
Dr. Ioannis Tarnanas, Ph.D. | Founder, Board Of Scientific Advisors | Leadership |
Antonella Chadha Santuccione | Chief Medical Officer | Leadership |
Brooks Kenny | Vice President of Marketing | Leadership |
Robbert Harms, PhD | Head of Data Science | Leadership |
Jennifer R. | Senior Sales Director | Leadership |
Shawn Fitzgerald | Head of Quality Management | Leadership |
Silvia Fallone | Senior Data Scientist | Team |
Jodi McGroarty | Manager, Customer Success | Team |
Jenna Hanson | Marketing Consultant | Team |
Nicholas Griffin, PhD | Senior Data Scientist | Team |
2 more people are available in the full profile.
Complete people profiles for Altoida
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Altoida
3 dated milestones of Altoida across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Altoida is founded.
- Funding First funding round of $33K.
- Funding Latest funding round, Series A, of $14.0M.
Web traffic of Altoida
The website of Altoida (altoida.com) receives about 31.7K visits a month and ranks #1,676,952 among all websites worldwide, #2,259 in Biotechnology and Pharmaceuticals.
- Monthly visits31.7K
▲ 93.5% vs previous month
- Unique visitors7.2K
per month
- Global rank#1,676,952
among all websites
- Category rank#2,259
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit1.5
- Average visit12 sec
- DevicesDesktop 36% · Mobile 64%
Websites whose visitors overlap most with Altoida. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| tfscro.com | 100% | 30.9K | #1,098,502 | View details | |
| neurologylive.com | 44% | 170.9K | #299,267 | View details | |
benenden.co.uk | benenden.co.uk | 44% | #165,154 | – | |
hra.nhs.uk | hra.nhs.uk | 44% | #273,703 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Altoida
Complete news archive for Altoida
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Altoida
Altoida was founded in 2016.
Altoida is headquartered in Lucerne, Switzerland. It is registered at Lucerne, Lucerne, Switzerland.
Richard Fischer is the CEO of Altoida, as recorded in our data. They have also founded this company.
Altoida is a funded company, having raised a total of $20.3M across 5 funding rounds to date. The company's 1st funding round was a Grant of $32.83K, raised on Jun 2016.
Altoida was founded in 2016 and is based in Lucerne, Switzerland. An AI-driven mobile application is offered by the company to forecast the early stages of Alzheimers disease. Interactive activities are incorporated to measure neuromotor biomarkers, which are processed for diagnostic insights. Operations are centered in the digital health sector, with a focus on neurodegenerative conditions and preventive assessments.
Altoida offers NeuroMarker Platform and Digital Cognitive Assessment.
Altoida has 11 investors. Key investors include M-Ventures, Whitecap VP, HonorHealth, Hikma Ventures, and Alpana Ventures.
Altoida operates through Altoida Inc.